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I.  INTRODUCTION 
John Doe was a student contemplating attending law school.1  Law school 
admissions, similar to admissions in most types of graduate and professional schools, 
                                                                
*JD expected 2008. The author would like to thank Professor Deborah Klein for her 
insight and input in advising the writing process. The author would also like to thank his 
family and friends for putting up with his many absences during the writing of this note. 
1Interview with Anonymous 2d Year Law Student, in Cleveland, Ohio (Sept. 21, 2006) 
[hereinafter Interview with John Doe.] The student, whose name was changed to John Doe to 
protect anonymity, admitted to taking Adderall before taking the Law School Admissions Test 
(LSAT).  Id. 
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are heavily dependent upon a student’s standardized test scores.2  John, having less 
than spectacular grades in college, knew that he would have to do very well on the 
Law School Admissions Test (hereinafter “LSAT”) in order to be accepted into any 
law school. 3 
John was an average test taker, and he had been scoring consistently in the mid 
150’s on his practice LSAT tests.4  He had heard from a friend that taking Adderall, a 
drug commonly prescribed for patients suffering from Attention Deficit 
Hyperactivity Disorder (hereinafter “ADHD”), could tremendously enhance one’s 
performance on standardized tests.  John obtained some Adderall tablets from one of 
his friends who had a prescription for the medication.  John took two of the tablets 
before the examination.5 
The drugs did not seem to take effect until the second (of six) thirty five minute 
sections.6  At that point, John indicated that the drugs started stimulating him – 
increasing his heart rate and body temperature.  In addition, he began to “think 
harder” and had little difficulty keeping his mind from wandering away from the 
LSAT problems.7  John had barely finished the first section before his time expired; 
however, he finished the second section and subsequent sections around five to ten 
minutes before his time expired.8  John scored a 162 on the actual examination.9  He 
attributes his approximate seven point increase to his illicit use of Adderall.10  
John is not the only student who has taken these types of prescription stimulants 
in an effort to enhance his academic performance.11  According to one study, 35.5% 
of undergraduate students have used these drugs in college, and one of the most 
                                                                
2Princeton Review, Dispelling the Myths about the LSAT and Law School Admissions, 
http://www.Princetonreview.com/law/testprep/testprep.asp?TPRPAGE=265&TYPE=LSAT 
(last visited Dec. 2, 2006).  The Princeton Review is one of the foremost and largest college 
and graduate school admissions counseling services.  Id. 
3Interview with John Doe,  supra note 1.  The LSAT is the “test required for admission to 
all ABA-approved law schools.”  Law School Admissions Council, About the LSAT, 
http://www.lsac.org/LSAC.asp?url=lsac/about-the-lsat.asp (last visited Oct. 22, 2006). 
4Interview with John Doe, supra note 1.  The LSAT is graded on a scale of 120-180.  Law 
school Admission Council, About the LSAT, http://www.lsac.org/LSAC.asp?url=lsac/about-
the-lsat.asp (last visited Oct. 22, 2006). 
5Interview with John Doe, supra note 1.  John Doe does not recall the dosage or specific 
type of Adderall that he consumed.  Id. 
6 Id. 
7Id.  The description of this experience is consistent with experiences of other students. 
See Adrianne Jeffries, Some Teens Abuse ADD/ADHD Drugs, THE VIRGINIAN-PILOT, March 
29, 2004 at E1.  It is commonly believed by students that Adderall and other prescription 
stimulants increase academic performance on tests.  Id. 
8 Id. 
9 Id. 
10Interview with John Doe, supra note 1. 
11See K. Graff Low & A.E. Gendaszek, Illicit Use of Psychostimulants Among College 
Students: a Preliminary Study, 7, No. 3 PSYCH. HEALTH, AND MED. 283, 283 (2002). 
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common stated reasons was to enhance academic performance.12  In light of the 
importance of standardized tests to admissions,13 it should not be surprising that 
these students are also using prescription stimulants in an effort to enhance their 
performance on tests as well. 
The perception that these drugs enhance one’s academic performance is common, 
especially among students.14  The same is true for drugs that some athletes illicitly 
take in order to enhance their physical performance.  Though many of these drugs 
taken to enhance one’s performance in athletics and academics do have a proven 
enhancing effect, many have not been proven to have any enhancing effect.  
Regardless of whether performance enhancing drugs actually improve an athlete’s 
performance, an athlete may not ingest a drug listed on the competition’s banned 
list.15 
This note will first give an overview of prescription stimulants and will then 
explore the prevalent number of students who illicitly take prescription stimulants to 
enhance their academic performance.  A description of how illicit use can be harmful 
to a student follows, and thereafter the note describes the scant current safeguards 
that currently exist against the use of illicit prescription stimulants.  An explanation 
of the importance of standardized test scores to admissions follows, along with a 
description of how this importance has motivated students to seek an unfair 
competitive edge through illicit drug usage, which happens in many sporting 
competitions.  The note will then explore the safeguards in place preventing illicit 
drug usage in sports and will argue that a similar random drug testing program 
should be implemented for students taking standardized tests. 
Finally, the note will explore possible objections to implementing a random drug 
testing program in standardized testing.  Some contend that these tests may constitute 
an illegal search and seizure of a person in violation of the Fourth or Fourteenth 
amendments.  In addition, some could contend that the proposed system of flagging 
scores of students taking prescription stimulants violates the Americans with 
Disabilities Act of 1990, 42 U.S.C.S. §§ 12101-12213 (LexisNexis 2007) 
(hereinafter “ADA”). These objections will be rebutted by an examination of legal 
precedent that demonstrates that random drug testing will not violate the Constitution 
or ADA.  
                                                                
12Id.   
13The 5 Most Important Factors in College Admissions, http://www.kaptest.com/Kaplan/ 
Article/College/College_Home/Apply_to_College/Prepare/CO_admiss_five2.html;jsessionid=
FQ1LFKPNX05GBLA3AQJHBOFMDUCBG2HB (last visited Dec.r 2, 2006).  This assertion 
is according to Kaplan, one of the foremost private for-profit organizations that focuses on 
helping students who seek admittance to colleges and graduate schools.  Id.   
14Low and Gendaszek, supra note 11, at 287.   
15See Ryan Connolly, Balancing the Justices in Anti-Doping Law: The Need to Ensure 
Fair Athletic Competition Through Effective Anti-Doping Programs vs. the Protection of 
Rights of the Accused Athletes, 5 VA. SPORTS & ENT. L.J. 161, 178-79 (2006). 
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II.  OVERVIEW OF PRESCRIPTION STIMULANTS 
ADHD is a disease that causes inattention, hyperactivity, and impulsivity in 
children and adults.16  Sufferers feel as if they always need to be moving, and they 
have difficulty concentrating on any particular subject or task.17  Prescription 
stimulants are the most common forms of drug treatment.18  These drugs “improve 
their [the patients’] ability to focus, work, and learn.”19 
Previously, a prescription stimulant was administered in an immediate-release 
form.20  Immediate-release stimulants begin affecting a patient within thirty minutes, 
generally peaking between one to three hours after ingestion.21  This rapidly-
absorbing version of the drug had the most potential for abuse.22  Fortunately, a new 
extended-release version of the drug was developed that had less potential for abuse 
among those seeking a “high.”23  These extended-release stimulants “are absorbed so 
gradually that they don’t cause a euphoric sensation and are therefore much less 
susceptible to misuse.”24  However, these stimulants are still susceptible to abuse 
among those who, without a prescription, wish to use them to enhance their 
academic performance. 
Many may think of ADHD as a disease that affects only children.  On the 
contrary, an estimated 1.5 million adults, 10% of them over the age of fifty, are now 
prescribed stimulants to treat ADHD.25  Treatment in adults, however, has not been 
found to be as effective as it has been for children.26  According to one study, only 
54% of adults treated with prescription stimulants responded to the therapy.27  
Approximately only half of adult users encounter any effect from ingestion of the 
prescription stimulant.28 
                                                                
16Nat’l Inst. of Mental Health, U.S. Dep’t of Health & Human Servs., Publ’n No. 94-3572, 
Attention Deficit Hyperactivity Disorder, at 2 (1996). 
17Id. 
18Id. at 22. 
19Id.  
20ADHD Update: New Data on the Risks of Medication, HARV. MENTAL HEALTH LETTER 
3, 3 (2006)[hereinafter ADHD Update].  
21P.J. Santosh & E.Taylor, Stimulant Drugs, 9 EUR. CHILD. & ADOLESCENT PSYCHIATRY 
I27 (2000).   
22ADHD Update, supra note 20, at 3.  
23Id.   
24Id.  
25Id. at 4. 
26 Santosh & Taylor, supra note 21, at I33.   
27 Id. 
28Id.  
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A.  Abuse 
Although prescription stimulants are often very successful in treating ADHD, 
“the increase in prescription rates has raised some public health concerns because of 
the potential abuse of these medications.”29  Studies have suggested that varying 
numbers of college students abuse prescription stimulants.30  According to one study, 
the non-medical use of Ritalin in 2003 was 5.7% for college students and 2.5% for 
those not attending college.31  However, another study found that as many as 35.5% 
of undergraduate students have illicitly used prescription stimulants.32  One study 
found that improving concentration was among the most prevalent reasons for their 
non medical use.33  Another study found that “[m]otivations were primarily 
academic.”34  This abuse was disproportionately high among white male students 
who are members of a fraternity, attend competitive colleges, and have lower grade 
point averages.35  
Additionally, increased proliferation of prescription stimulants has likely aided in 
their abuse.  Between 2000 and 2004, prescriptions for these medications increased 
from 1.6 million per month to 2.6 million per month.36  Many factors may contribute 
to this increase such as heightened awareness of ADHD and its potential for 
treatment and the erosion of the stigma surrounding psychological disorders.37 
Another likely factor is the discovery that these drugs may enhance one’s academic 
performance. 
B.  Academic Enhancing Effect 
These stimulants have proven to enhance the academic performance of the user, 
regardless of whether he has been diagnosed with ADHD.38  According to Dr. Eric 
Heiligstein, a psychiatrist who studies substance abuse at the University of 
Wisconsin, ADHD drugs can give the user almost “super human ability to focus for 
                                                                
29Sean McCabe et al., Non-medical Use of Prescription Stimulants for Treating Symptoms 
of ADHD, SOC’Y FOR THE STUDY OF ADDICTION, Aug. 2005, at 96, 97.  
30 See Id. 
31Id.  
32Low & Gendaszek, supra note 11, at 284.  
33McCabe et al., supra note 29, at 102.   
34Low & Gendaszek, supra note 11, at 283. 
35McCabe et al., supra note 29, at 96. 
36Nicholas Zamiska, Pressed to Do Well on Admissions Tests, Students Take Drugs --- 
Stimulants Prescribed for Attention Disorders Find New Unapproved Use, WALL ST. J., Nov. 
8, 2004, at A1. 
37The general understanding of what ADHD is, how it is caused, and possible treatment 
continues to increase as more studies are conducted.  See generally Attention Deficit 
Hyperactivity Disorder, The National Institute of Mental Health 
http://www.nimh.nih.gov/health/publications/adhd/minhadhdpub.pdf  (2006). As a result, 
more children who have the disorder are properly diagnosed with it.  Id. 
38Andrew Conte, More Students Abusing Hyperactivity Drugs, PITTSBURGH TRIB. REV., 
Oct. 25, 2004, available at http://www.pittsburghlive.com/x/pittsburghtrib/print_265518.html. 
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long periods of time.”39  Dr. Heiligstein went on to describe Adderall as an 
“academic steroid.”40  Studies conducted by the National Institute of Health in the 
1970s have confirmed this statement by showing that stimulants increase 
concentration in healthy individuals.41  Anita Barkin, the director of the Student 
Health Services at Carnegie Mellon University, said “Adderall and Ritalin are 
getting to be the drugs of choice for students who believe they will enhance their 
performance on tests or help them study more effectively.”42 
Amphetamines, such as Adderall and Ritalin, mimic the dopamine 
neurotransmitter in the brain.43  According to a study of healthy non-ADHD adults, 
published in the American Journal of Psychiatry, increased dopamine levels 
correspond with enhanced interest in the activity at hand.44  This enhanced interest is 
likely the reason why stimulants are generally known to enhance academic 
performance.45  Prescription stimulants have also been proven to enhance the 
academic performance of those diagnosed with ADHD.46  One study showed that 
students diagnosed with ADHD, who were given prescription stimulants, attempted 
more math problems on a standardized test and had a higher accuracy percentage.47   
It is documented that students are abusing prescription stimulants to enhance 
their academic performance in college.48  It is probable that they, like John Doe, are 
using these stimulants to enhance their performance in other academic areas such as 
when taking standardized tests.  Not only does abuse in this way give those who 
break the rules an unfair competitive edge, it can also be very harmful to these 
abusers as well. 
                                                                
39Id. 
40Id. 
41Zamiska, supra note 36. 
42Conte, supra note 38. 
43Nora Volkow, et al., Evidence that Methylphenidate Enhances the Saliency of a 
Mathematical Task by Increasing Dopamine in the Human Brain, 161 AM J. PSYCHIATRY. 
1173-80 (2004).  
44Id. at 1173. 
45Id. at 1179. 
46See Regina S. James et al., Double-Blind Placebo-Controlled Study of Single-Dose 
Amphetamine Formulations in ADHD, 40 (11) J. OF THE AM. ACAD. OF CHILD AND 
ADOLESCENT PSYCHIATRY 1268 (2001). 
47Id.  Thirty five students were given Adderall, immediate release dextroamphetamine, and 
a placebo over an 8 week period. Id.  The students mentioned in the above text were those 
taking dextroamphetamine, which is a main active ingredient in Adderall.  Id.  The test was 
administered four hours after the drug was given.  Id.   Notably, the children taking Adderall 
did not differ in scores from those taking the placebo.  Id.   However, the study administrators 
attributed this to timing – Adderall reaches maximum efficacy two hours after administration.  
Id.   What is important is that a major active ingredient in Adderall has been proven to have an 
academic enhancing effect on children with ADHD. See Id.   
48See Id. 
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C.  Harmful Effects  
Prescription stimulant abuse can have harmful effects on the abuser. According 
to Dr. Nora Volkow, Director of the National Institute on Drug Abuse, prescription 
stimulants have a high potential for abuse.49  Especially when taken in high 
concentrations, these drugs, like cocaine, increase the dopamine level in the user’s 
brain.50  This increase creates a euphoric sensation in the user, and the user becomes 
accustomed to the high dopamine levels.51  The desire to re-create this feeling is what 
causes addiction.52  According to Dr. Volkow, the “misperception of safety [in using 
prescription stimulants] may contribute, for example, to the casual attitude of many 
college students towards abusing stimulants to improve function and academic 
performance.”53 
Overuse of prescription stimulants because of addiction can lead to elevated 
blood pressure, increased heart and breathing rates, sleep deprivation, and paranoia.54  
The effects obviously damage an abuser’s heart and psyche.55  In 2005, Canada 
removed Adderall XR56 from the market because of twenty recent deaths and twelve 
strokes attributed to ingestion of the drug.57  Thus, not only does illicit use of 
prescription stimulants give the abuser an unfair competitive edge over those 
legitimately taking standardized tests, it also poses a serious health risk to the abuser. 
D.  Current Safeguards against Non-Prescribed Use 
Currently, drugs like Adderall and Ritalin are available only with a prescription.58  
Under the Controlled Substances Act, these drugs are classified as Schedule II 
controlled substances.59  As such, non-prescribed possession of these drugs violates 
federal law.60  Illicit possession of Schedule II drugs can result in up to one year in 
                                                                
49Prescription Drug Abuse: Statement Before the Subcomm. on Crim. Justice, Drug 
Policy, & Human Resources, 109th Cong., 2 (2006) (statement by Dr. Nora D. Volkow, M.D., 
Director of the National Institute on Drug Abuse at the National Institutes of Health). 
50Id. 
51Id. 
52Id. 
53Id. 
54Id. 
55ADHD Update, supra note 20. 
56This is the extended release version of the medication. Id. 
57ADHD Update, supra note 20. 
58Adderall Overview, http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/add1008. 
shtml (last visited Feb. 3, 2007); Ritalin Overview, http:www.pdrhealth.com/drug_info/rxdrug 
profiles/drugs/rit1383.shtml. (last visited Feb. 3, 2007)  
5921 U.S.C.S. § 812 (LexisNexis 2006).  
6021 U.S.C.S. § 844 (LexisNexis 2006).  The relevant part of the statute reads as follows: 
“Unlawful acts; penalties. It shall be unlawful for any person knowingly or intentionally to 
possess a controlled substance unless such substance was obtained directly, or pursuant to a 
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prison and a minimum fine of $1,000 for the first offense.61  The penalty 
substantially increases for subsequent offenses.62  Thus, anyone who illicitly 
procures these drugs and takes them to enhance academic performance on 
standardized tests, violates a federal law that imposes stiff penalties. 
However, standardized tests, such as the LSAT, do not specifically prohibit non-
prescribed use of these drugs.63  Accordingly, no mechanism of enforcement exists 
aimed at preventing students from obtaining the unfair competitive edge resulting 
from illicit use of prescription stimulants.64 Abusers can easily obtain these drugs,65 
and it is doubtful that law enforcement is successful in apprehending and punishing 
these people for their contravention of federal law.  Not only should the 
organizations responsible for administering these standardized tests address the 
problem by specifically banning illicit use of prescription stimulants, they must also 
implement an effective mechanism of enforcement.  This mechanism comes in the 
form of random drug testing similar to that instituted by the organizers of many 
competitive sporting events. 
III.  THE IMPORTANCE OF STANDARDIZED TESTING TO ADMISSIONS 
Standardized tests are becoming increasingly important in college and graduate 
admissions decisions.66  High schools and colleges are very diverse, and it is often 
difficult to compare the grade point averages of their students because of the 
corresponding diversity in the schools’ grading standards. 67  Standardized test scores 
are a uniform criterion that can be used to directly compare students.  Accordingly, 
“standardized tests have become the one factor that admissions departments can use 
[to] easily – and cheaply – distinguish between candidates.”68 
The LSAT, specifically, is a highly weighed criterion in law school admissions. 
According to the University of California at Berkeley’s Boalt School of Law, “[t]he 
LSAT score is a very important admission factor.”69  In fact, it is often considered 
the most important admissions criterion for law schools.70  Because admissions are 
                                                           
valid prescription or order, from a practitioner, while acting in the course of his professional 
practice, or except as otherwise authorized by this title or title III.” 
61Id. 
62Id.  
63 See LSDAS, LSDAS Candidate Requirements, http://www.lsat.org/applying/lsdas-
candiate-requirements.asp (last visitied Jan. 9, 2008). 
64 Id. 
65U.S. DEP’T OF JUSTICE, DRUGS OF ABUSE 35 (2005), http://www.usdoj.gov/dea/pubs/ 
abuse/doa-p.pdf.  
66See The 5 Most Important Factors in College Admissions, supra note 13. 
67Id. 
68Id. 
69University California, Berkeley Boalt School of Law, Admissions Frequently Asked 
Questions, http://www.law.berkeley.edu/admissions/jddegree/faq.html#Q6 (last visited Dec. 4, 
2006). 
70Princeton Review, supra note 2. 
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so heavily dependent upon these scores, it is not surprising that students are greatly 
concerned with their performance on these tests.   
Because these tests are often the one standardized criterion that schools can use 
to compare students, it is important that their standardized nature be preserved. 
Anyone taking prescription stimulants are put at an unfair competitive edge vis-à-vis 
those who take the tests in a legal manner.  In this way, the standardized nature of the 
test is not preserved, and thus one of the major purposes of the test is defeated.71 
Whatever the actual proportion is, many students illicitly use prescription 
stimulants to enhance their academic performance in school.72  Because standardized 
test scores are weighted so heavily in admissions considerations, it is probable that 
there are more students like John Doe abusing prescription stimulants to enhance test 
scores.  A deterring system, similar to that found in sports law, should be 
implemented to help prevent this unfairness. 
IV.  ANTI-DOPING EFFORTS IN SPORTS LAW73 
A.  United States Anti-Doping Agency’s Method 
Generally, anti-doping efforts in sports are the products of contract law.74  When 
athletes enter into a competition, they often sign contracts in which they agree not to 
use certain substances, although legal, that will unfairly enhance their performance.75  
If athletes are found guilty of a doping violation,76 they are generally disqualified 
from the current competition and sometimes suspended or banned from subsequent 
competitions.77 
Though some sports organizations have their own rules and procedures for drug 
testing, many follow the United States Anti-Doping Agency’s example (hereinafter 
“USADA.”)  The USADA, founded in 2000, is responsible for managing the testing 
of U.S. athletes who participate in the Olympics, the Pan-Am Games, and the 
Paralympics.78  It was formed as a reaction to the increase in athletes who use 
performance enhancing drugs and as an attempt at credible regulation of this 
                                                                
71This assertion has been noted by the courts, specifically regarding the LSAT: “The 
LSAC has a legitimate interest in preserving, to the extent possible, the standardized format of 
the LSAT, and it has an obligation to all candidates who take the LSAT and to the law schools 
which rely on the formats to preserve the standardized format.” Badgley v. LSAC, Civil 
Action No. 4:99CV-0103-M 2000 U.S. Dist. LEXIS 16925, at *2 (N.D. Tex. Aug. 24, 2000). 
72Low & Gendaszek, supra note 11, at 283-84. 
73“Doping” is the process of taking illicit drugs to enhance one’s performance. 
74Connolly, supra note 15, at 174-75. 
75 Id. 
76The term “doping violation” is used when an athlete tests positive for a banned 
substance. 
77Id.at 178. 
78USADA Mission, http://www.usantidoping.org/who/mission.html (last visited Sept. 23, 
2006). 
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phenomenon.79  In a contract between the United States Olympic Committee and the 
USADA, the USADA has agreed to not only conduct all drug tests of U.S. Olympic 
athletes, but also to manage the data collection and oversee adjudication of any 
testing disputes.80  The USADA may relay any information it procures incident to 
testing to the relevant governing bodies of the sport in question.81 
Testing for banned substances occurs both in and out of competition.82  Out-of-
competition testing occurs year round, and an athlete is selected at random.83  The 
USADA attempts to collect samples at times more highly susceptible to doping.84  In 
contrast to out-of-competition testing, athletes tested in-competition are generally not 
selected at random.  Rather, they are selected according to the athlete’s position in 
that specific competition.85 
Samples are collected either by USADA representatives or other USADA-
authorized individuals,86 who are often officials from other anti-doping 
organizations, such as the World Anti-Doping Agency (hereinafter “WADA”).  The 
WADA is an international independent organization that coordinates and monitors 
anti-doping policies in international competition.87  Results are generally reported to 
the USADA within ten working days of the laboratory’s receipt of the testing 
sample.88  Retesting occurs only at USADA direction.89 
If the USADA receives a negative lab report, the USADA promptly notifies the 
athlete.90  Penalties for a confirmed positive test are expansive.91  They have ranged 
                                                                
79USADA History, http://www.usantidoping.org/who/history.html (last visited Sept. 23, 
2006). 
80U.S. Anti-Doping Agency, Protocol for Olympic Movement Testing 2 (2004) 
http://www.usantidoping.org/files/active/policies_procedures/2004%20USADA%20Protocol
%5B3%5D.pdf [hereinafter Protocol for Olympic Movement Testing]. 
81Id. 
82Doping Control Process, http://www.usantidoping.org/what/process/selection.html (last 
visited Sept. 23, 2006). 
83Doping Control Process, Notification, 
http://www.usantidoping.org/what/process/notification.html (last visited Jan. 6, 2008).    
84Doping Control Process, supra note 82.  
85Id. For instance, any competitor who finishes the competition in third place may be pre-
selected for testing.  
86Protocol for Olympic Movement Testing, supra note 80, at 4. 
87See Id.   
88Id.  
89Id.  
90See Protocol for Olympic Movement Testing, supra note 80, at 5. 
91See Sanctions, http://www.usada.org/what/management/sanctions.aspx (last visited Dec. 
2, 2006).  
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from a mere public warning,92 to temporary suspensions from participating in that 
sport, to permanent expulsion.93 
B.  Therapeutic Use Exemptions 
Athletes may qualify for a “therapeutic use exemption” for a drug normally 
prohibited but legally prescribed to them.94  An athlete must apply for this exemption 
at least twenty-one days in advance of the competition, and there is no guarantee that 
the exemption will be granted.95  
The USADA specifically addresses therapeutic use exemptions for drugs used to 
treat ADHD.96  In addition to completing a form describing the nature of the use and 
the disorder, the athlete must also submit the following information:  medical reports 
concerning the diagnosis; a family history related to the diagnosis; psychological 
evaluations; a description of how the medication is supposed to help treat the 
disorder; and “[e]vidence that allowed medications have been considered or tried and 
that the outcome of use of the allowed medications is such that the prohibited 
medication must be used.”97 
V.  USADA ANTI-DOPING LAW: A SHIFTING OF BURDENS 
When the athlete undergoes testing that is analyzed in a USADA-approved lab, 
the process is presumed accurate.98  Generally, these labs are approved by the 
WADA.99  In testing, these labs must follow the WADA’s International Standard for 
Laboratory Analysis.100  
If an athlete tests positive for a banned substance, a prima facie case of guilt is 
established.101  Whether the banned substance did or is likely to have an effect on the 
athlete’s performance is immaterial in this analysis.102  The athlete’s mental state is 
likewise immaterial, regardless of whether he intentionally ingested the banned 
                                                                
92Id. Generally these include very minor infractions, such as testing positive for 
psuedophedrine, a common ingredient in over-the-counter nasal decongestants.  Id.  
93Id.  
94U.S. Anti-Doping Agency, USADA, Forms, http://www.usantidoping.org/dro/resource/ 
forms.aspx (last visited September 23, 2006). 
95 Id. 
96See USADA, TUE Requirements for ADD and ADHD Medications (2005), 
http://www.usantidoping.org/files/active/athletes/standard%20tue.pdf. 
97Id.   
98See Connolly, supra note 15, at 177. 
99World Anti-Doping Agency, Mission, http://www.wada-ama.org/en/dynamic.ch2?page 
Category.id=255 (last visited Feb. 5, 2007). 
100See Protocol for Olympic Movement Testing, supra note 80, at 2. 
101See Slaney v.  Int’l Amateur Athletic Fed’n, 244 F.3d 580, 589 (7th Cir. 2001).   
102Oliver Niggli & Julien Sieveking, Selected Case Law Rendered Under the World Anti-
Doping Code, JUSLETTER (Independent Swiss Legal Newsletter, Geneva, Switzerland), Feb. 
2006, at 7, available at http://www.wada-ama.org/rtecontent/document/jusletter-eng.pdf. 
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substance.103  In this sense, establishing the initial presumption of guilt can be 
likened to strict liability – if there is a positive test, then there is a presumption of 
guilt.104  The actor’s mental state and the actual effect of the drug are irrelevant.105 
An athlete, however, may rebut this presumption.106  Since it is immaterial 
whether the drug actually affected the athlete’s performance or whether the athlete 
intended to ingest it, the athlete’s best defense to this established presumption is to 
show that the testing procedure was flawed.107  Tests conducted by credible agencies 
are generally presumed accurate.108  The athlete may proffer affirmative evidence 
that a specific part of the testing procedure was deficient, causing an incorrect test 
result.109 
The standard of proof that must be met in order to rebut this prima facie case of 
guilt is the “comfortable satisfaction standard.”110  In the arbitration hearing of De 
Bruin v. Fina, CAS 98/211, Award of 7 June 1999, CAS Digest II,111 the arbitration 
panel described this standard as “high: less than the criminal standard,112 but more 
than the ordinary civil standard.”113  
In addition to banning certain types of substances, regulating agencies also 
prohibit athletes from having an extra-normal amount of naturally occurring 
substances in their bodies (such as testosterone).114  Under the USADA’s framework, 
if an athlete tests positive for a prohibited amount of testosterone, the athlete will be 
promptly notified, as he would with any positive test.115  The laboratory will then 
conduct a second test in which the athlete is permitted to bring a “representative.”116  
The athlete will be provided the results of the first test that showed that the athlete 
                                                                
103Connolly, supra note 15, at 179. 
104Id.  
105Id. 
106Id. at 177. 
107Id. 
108Id. These include the USADA.   
109Id.  
110Id. 
111See generally Connolly, supra note 15 (because doping violations are contract disputes, 
they generally are settled by arbiters and mediators rather than proceeding to court).  
112The criminal standard is “beyond a reasonable doubt,” which is a higher standard than 
required in civil cases. 1 LAIRD KIRKPATRICK & CHRISTOPHER MUELLER, FEDERAL EVIDENCE § 
77 (2d ed., Lawyers Cooperative Publishing, 1994).   
113De Bruin v. Fina, CAS 98/211, Award of 7 June 1999, CAS Digest II at 266. The civil 
standard is “upon a preponderance of the evidence,” which indicates that the evidence if more 
likely than not to be true. LAIRD & MUELLER., supra note 112, at § 65.  The standard described 
in De Bruin seems to fall somewhere between this standard and the criminal standard. 
114See Slaney, 244 F.3d at 589. 
115Protocol for Olympic Movement Testing, supra note 80, at 5 
116Id.  This witness, presumably, would be legal counsel, or someone else knowledgeable 
of the testing procedure or governing law, though it is not required. 
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tested positive for elevated levels of testosterone.117  Further action is not taken 
unless the second test confirms the first or the athlete waives the second test.118 
In one such case, an athlete tested well over the acceptable rate for 
testosterone.119  The court held that this testing was enough to establish the prima 
facie case of guilt, and “the burden [then] shifted to the athlete, who must prove by 
clear and convincing evidence120 that the elevated T/E [testosterone] ratio was due to 
pathological or physiological conditions.”121  This is the same system of burden-
shifting used to establish and rebut liability for banned substances. 
A.  Appeals and Review Board  
Some athletes may wish to appeal the USADA’s finding; in anticipation of such 
appeals, the USADA devised the USADA Anti-Doping Review Board (hereinafter 
“Review Board.”)122  The Review Board examines all samples that the lab indicated 
tested positive for a banned substance, or for an elevated level of a naturally 
occurring substance.123  A positive test is reviewed by at least three members of the 
Review Board, which is comprised of at least one medical expert, one technical 
expert, and one legal expert.124 All of these members must be employed 
independently from the USADA.125   
If a doping violation is found, the violator is promptly notified within ten days 
that he tested positive for an illicit substance.126  Appeal of a positive test must be 
submitted in writing to the Review Board.127  This is not a deliberative hearing in any 
sense.  An athlete submits his appeal and then is not afforded any opportunity to 
further argue the merits of his claim.128  The Review Board considers the writing and 
makes a recommendation to the USADA as to whether there is sufficient evidence to 
begin an adjudication process.129  Upon issuance of the USADA’s decision to the 
athlete, the athlete will have ten days to determine whether he wishes to proceed in 
                                                                
117Id.   
118Id.   
119Slaney, 244 F.3d at 584. 
120 The “clear and convincing” standard is “a greater burden than preponderance of the 
evidence . . . but less than evidence beyond a reasonable doubt” BLACK’S LAW DICTIONARY 
250 (2d pocket ed. 2001).  This standard seems to be close if not identical to the “comfortable 
satisfaction” standard described in De Bruin. 
121See Slaney, 244 F.3d at 593. 
122Protocol for Olympic Movement Testing, supra note 80, at 7. 
123Id.  
124Id.  
125Id.  
126Id. at 8.  
127Id.  
128Id.  
129Id.  
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the adjudication process.130  If he does not give notice that he wishes to continue with 
the adjudication process, then he will be sanctioned.131  If an athlete claims that he 
did give notice, but the Review Board claims that they received no notice, then the 
athlete must show by a preponderance of the evidence that notice was given.132  
B.  Arbitration 
If the adjudication process continues, then the claim is submitted to the American 
Arbitration Association.133  The USADA has the right to request that other parties, 
such as the WADA, be represented at the hearing.134  The athlete has the sole right to 
request that the hearing be open to the public.135 
The final decision by the arbitration panel may be further appealed to the Court 
of Arbitration for Sport (hereinafter “CAS”).136  The arbitration occurs in the CAS’s 
New York office,137 and the court reviews the matter de novo.138  The CAS shall have 
the authority to increase, decrease, or void the sanctions the USADA imposed on the 
athlete.139  The CAS decision shall be final and binding.140 
C.  The National Collegiate Athletic Association’s Example 
The National Collegiate Athletic Association (hereinafter “NCAA”) is an 
organization that colleges and universities join to regulate inter-collegiate athletic 
competitions.141  Over 1,250 institutions belong to this organization, including all 
                                                                
130Id.  (the athlete may be entitled to one five day extension to make this decision).  
131Id.  
132Id. at 9.  
133Id. at 10  
134Id. at 10.  
135Id.   
136Id. The Court for the Arbitration of Sport was founded in 1984 by a special committee 
of the International Olympic Committee. It is an international organization with offices in 
Lausanne, Switzerland, Sydney, Australia, and New York City, U.S. Most Olympic and non-
Olympic organizations recognize the authority of the court. Tribunal for the Arbitration of 
Sport, History, http://www.tas-cas.org/en/histoire/frmhist.htm (last visited Feb.7, 2007). 
137Protocol for Olympic Movement Testing, supra note 80, at 10. 
138A de novo appellate review is defined as “A court’s non-deferential review of an 
administrative decision, usually through a review of the administrative record plus any 
additional evidence the parties present.” BLACK’S LAW DICTIONARY 382 (2d pocket ed. 2001).   
139 Protocol for Olympic Movement Testing, supra note 80, at 10.  
140Id. at 10.  
141The National Collegiate Athletic Association, About the NCAA, http://www2.ncaa.org/ 
portal/about_ncaa/ (last visited Feb. 3, 2007). 
2007-08] COMBATING THE UNFAIR COMPETITIVE EDGE 165 
major colleges and universities.142  Its mission is to “govern competition in a fair, 
safe, equitable, and sportsmanlike manner.143  
In 1986 and 1990, the NCAA adopted Proposal Numbers 20, 52, 53, and 54, in 
which each member affirmed its dedication to fair competition.144  In that effort, the 
NCAA implemented drug testing of member institutions’ athletes.145  This was done 
to ensure that no athlete obtained any kind of unfair competitive edge over others, to 
prevent encouraging innocent athletes from having to use banned substances in order 
to keep up with those already using illicit drugs, and to safeguard the health and 
safety of its participants.146 
According to the NCAA’s constitution, students must sign consent forms for any 
drug testing conducted year-round, though testing sometimes occurs only during in-
season.147  NCAA bylaw 31.2.3.4 gives a list of banned substances, among which are 
Adderall, Ritalin, and other prescription stimulants.148  If the athlete tests positive for 
one of these substances, then he is banned from competition for a particular amount 
of time.  If the positive test occurred before the season of the athlete’s competition, 
the athlete is banned from competition for that entire season.149  The minimum ban is 
one season.150  If the athlete tests positive after already having started the season, 
then he is ineligible for the remainder of that season and also for a portion of the next 
season, sufficient to bring the total banned time to one full season.151  In most cases, 
the athlete is ineligible for the calendar year following a positive test.152  After a 
probationary period, the athlete must test negative on a subsequent test and be 
approved by the Committee on Student-Athlete Reinstatement.153  If he tests negative 
and is approved, then he may be reinstated.  A failure to show for a scheduled drug 
                                                                
142Id.   
143The National Collegiate Athletic Association, Our Mission, http://www2.ncaa.org/ 
portal/about_ncaa/overview/mission.html (last visited February 3, 2007). 
144NCAA, Drug Testing Program 1 (2006-07), http://www.ncaa.org/library/sports/-
sciences/drug-testing-program/2007-08/2007-08-drug-testing-program.pdf. 
145Id. 
146Id. 
147NCAA Const. Art. 3.2.4.7.1 10 (2006-07), 
http://www.ncaa.org/library/membership/division_i_manual/2006-07/2006-
07_d1_manual.pdf. This depends on the sport in question. See Id. 
148NCAA Operation Bylaws 31.2.3.4 422-23 (2006-07), 
http://www.ncaa.org/library/membership/division_i_manual/2006-07/2006-
07_d1_manual.pdf. 
149NCAA, Drug Testing Program, supra note 144, at 3. 
150Id.  
151 NCAA Operation Bylaws 18.4.1.5.1 382 (2006-07), 
http://www.ncaa.org/library/membership/division_i_manual/2006-07/2006-
07_d1_manual.pdf. 
152Id. 
153Id..   
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test or proven tampering with a test is considered a positive test for purposes of 
determining eligibility.154 
Actual testing occurs both in-season and out of season.155  Testing can occur at 
random times or immediately subsequent to a competition.156  Testing following a 
competition is contingent upon an athlete’s place in the competition.157  For instance, 
the first place finisher, whoever it may be, is pre-selected for testing.158  The athlete 
is given time to talk to reporters, collect his award, and to handle incidentals, but 
then he must immediately proceed to the on-site testing facility.159  The facility itself 
and the actual administration160 of the test is conducted by the National Center for 
Drug Free Sport.161 
When an athlete is tested, he may bring a witness to verify that all testing 
procedures comply with NCAA protocol.162  An athlete is required to urinate into a 
container, and an official at the testing agency of the same gender observes in order 
to ensure that no tampering has occurred.163  In order to induce urination, an athlete 
may be given fluids that do not contain banned substances.164  The observer then 
packages the specimen and ships it to a National Drug Free Sport testing center.165 
Consequences for testing positive are greater if the banned substance is classified 
as a “street drug.”166  These include heroin, marijuana, and tetrahydrocannabinol 
(THC).167  If an athlete tests positive for a second time for one of these drugs, he 
                                                                
154Id. 
155Video: NCAA Drug Education and Testing Video (NCAA 2007), http://ncaa.org 
[hereinafter NCAA Video] (follow "Legislation and Governance” hyperlink; then follow 
“Drug Testing” hyperlink; then follow "NCAA Drug Education and Testing Video” 
hyperlink). 
156Id. 
157 Id. 
158Id. 
159Id. 
160NCAA, Overview of the NCAA Year-Round Drug-Testing Program, 
http://www1.ncaa.org/membership/ed_outreach/health_safety/drug?testing/year?round?overvi
ew.html (last visited Jan. 7, 2008). 
161The National Center for Drug Free Sport, History, http://www.drugfreesport.com/who-
we-are.html (last visited Feb. 4, 2007).  The National Center for Drug Free Sport is an 
organization founded specifically to address the drug testing needs of sports organizations, 
like the NCAA.  Id.   In addition to actually conducting and administering drug tests, Drug 
Free Sport also helps organizations develop drug testing programs. Id. 
162NCAA Video, supra note 155. 
163Id. 
164Id. 
165 Id. 
166NCAA Operation Bylaws 18.4.1.5.1 382 (2006-07), http://www.ncaa.org/library/ 
membership/division_i_manual/2006-07/2006-07_d1_manual.pdf. 
167 NCAA, Drug Testing Program, supra note 144, at 3. 
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becomes ineligible not only for the remainder of his current season, but also for the 
next calendar year.168 
According to the NCAA Constitution Article 18.4.1.5.1.2, the athlete’s institution 
may appeal the duration of ineligibility.169  The Committee on Competitive 
Safeguards and Medical Aspects of Sports may reduce the penalty up to 50%, or in 
some cases, grant complete relief.170  If the athlete has tested positive for a banned 
substance in a test conducted by any other organization who has adopted the World 
Anti-Doping Agency’s Code,171 such as the USADA, then the athlete is ineligible for 
the period the other organization has banned him.172 
Methylpenidate (Ritalin) is on the NCAA’s list of banned substances.173  
However, the athlete may qualify for a medical exception, which is similar to the 
USADA’s therapeutic use exemption.174  The NCAA’s Executive Committee makes 
this decision according to the athlete’s documented medical history and current 
need.175  The committee recommends that the athlete first pursue alternative 
treatments that do not involve banned substances.176  However, if there is no 
appropriate alternative treatment, the athlete may continue to use the substance.177  
Any anabolic or peptide hormone use must first be approved by the NCAA.178 
Pre-approval is likely required because those hormones have a high likelihood of 
eliciting a performance-enhancing effect and are, therefore, the most abused.  If the 
athlete seeks NCAA approval of his medical use of anabolic agents or peptide 
hormones, then his institution’s director of athletics must submit a request to the 
National Center for Drug Free Sport.179 
                                                                
168NCAA Operation Bylaws 18.4.1.5.1 383 (2006-07), http://www.ncaa.org/library/ 
membership/division_i_manual/2006-07/2006-07_d1_manual.pdf. 
169Id. 
170Id. 
171The World Anti-Doping Agency is an “international independent organization created 
in 1999 to promote, coordinate, and monitor the fight against doping in sport in all its forms.” 
World Anti-Doping Agency, Mission and Priorities, http://www.wada-ama.org/en/dynamic. 
ch2?pageCategory.id=255 (last visited Feb. 11, 2007). 
172 NCAA Operation Bylaws 18.4.1.5.1 382 (2006-07), http://www.ncaa.org/library/ 
membership/division_i_manual/2006-07/2006-07_d1_manual.pdf. 
173NCAA Drug-Testing Programs Site Coordinator Manual 30 (2006-07), http://www. 
ncaa.org/library/sports_sciences/drug-testing_manual.pdf. 
174NCAA Operation Bylaws 31.2.3.5 423 (2006-07), http://www.ncaa.org/library/ 
membership/division_i_manual/2006-07/2006-07_d1_manual.pdf. 
175NCAA, Drug Testing Program, supra note 144. 
176NCAA, 2007-08 Drug-Testing, Exceptions Procedures, 
http://www.ncaa.org/membership/ed_outreach/health_safety/drug_testing/exceptions.html 
(last visited Jan. 9, 2007). 
177Id. 
178Id. 
179Id.  
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For any medical use exception, the institution must keep documentation that 
supports and explains the athlete’s medical condition and why the substances are 
necessary to treat it.180  Unless the substance in question is an anabolic agent or 
peptide substance, these records may be kept confidential in the member institution’s 
files, and they need not be sent to the NCAA.181  If the athlete tests positive for a 
banned substance and had not pre-notified the NCAA, the athlete’s director of 
athletics may request a medical exception.182  This request is sent to Drug Free Sport, 
and the athlete remains eligible until a final decision is made.183  Drug Free Sport, 
along with the NCAA’s chair of the drug-testing and drug education subcommittee, 
review the request and relevant medical documentation to determine whether to grant 
an exception.184  Drug Free Sport then informs the athlete’s director of athletics 
whether an exception will be granted.185  
Currently, no system similar to that imposed by the NCAA or the USADA exists 
that discourages students from taking prescription stimulants before standardized 
tests.  If a student knows that he may be subjected to drug testing, he will be far less 
likely to illicitly ingest the drug.  Because these drugs have a proven academic 
enhancing effect, and because the nature of admissions has become more and more 
competitive and contingent upon standardized test scores, more and more students 
will seek the performance enhancing effect of these drugs.  If this trend continues, 
students who generally take the test without the use of performance drugs may be 
induced to take these drugs in order to keep up with the competition.  Something 
needs to be done to prevent this snowball effect from occurring.  The obvious answer 
is to implement random drug testing similar to those the NCAA and USADA use. 
VI.  THE SOLUTION 
Random drug testing, similar to that instituted by the USADA and the NCAA, 
should be implemented.  The organization administering the standardized test should 
require all students to register for possible drug testing when these students register 
for the written test.  
Drug testing should occur at random, and tests should be administered 
immediately after the student takes the standardized test.  Because of the expense 
involved with administering drug testing,186 it is likely that only a small percentage 
                                                                
180Id. 
181Id. 
182Id. 
183Id. 
184Id.  
185Id. 
186See Congressional Budget Office, H.R. 2565, A bill to reauthorize the Office of 
National Drug Control Policy Act and to establish minimum drug-testing standards for major 
professional sports leagues 5 (2005), http://www.cbo.gov/ftpdoes/ 65xx/doc6535/hr2565.pdf 
(testing adhering to USADA standards costs approximately six hundred dollars per test).  
Though it is unconfirmed exactly how much a similarly effective test for prescription 
stimulants would cost, this expense would certainly not be negligible.  
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of students could actually be tested.  However, fear of drug testing should discourage 
many students from illicitly taking these stimulants before a standardized test.187 
Every student should be presumed innocent, and a student who is medically 
prescribed these stimulants should qualify for a therapeutic use exemption.  Only 
upon testing positive for a banned substance should the student be deemed 
presumptively guilty.  The student, however, should be given an opportunity to rebut 
this presumption of guilt by showing that the testing was in some way inaccurate.  
It should be immaterial whether the drug had an actual effect on the student’s 
performance or whether ingestion was intentional.  In this sense, the standard should 
be similar to the USADA’s system of strict liability.188  If a student tests positive for 
illicit prescription stimulants and is unable to rebut this presumption, then the student 
is deemed guilty.  This will eliminate litigation expense that could be expended by 
students who may argue that their ingestion was unintentional.  It would be 
immaterial whether the student intended on ingesting the drug – if he tests positive, 
and he cannot prove that testing was inaccurate, then he is guilty.  Since mental state 
is not an issue, it could not be litigated.  This strict liability system should aid in 
keeping expenses related to the program as low as possible. 
If guilt is established, then the student should be subjected to consequences.  
These consequences should be harsh in order to strongly deter students from 
ingesting these substances.  Because the system imposes strict liability, a student 
who recklessly or negligently ingests the substance is just as liable as a person who 
purposely ingests it.  Harsh consequences will compel students to exercise a high 
standard of care in preventing themselves from inadvertently ingesting these 
substances and deter purposeful violators. 
Consequences will be left within the purview of the admissions committee 
considering the positive-testing student’s application.  The scores of these students 
should be flagged as having been procured while illicitly under the influence of 
prescription stimulants.  If this student takes the test again, regardless of whether he 
is tested and tests positive for illicit prescription stimulants, the fact that he once 
violated the rules should be reported to any institution to which he applies. 
In this system, the decision whether to suspend or completely preclude a 
violator’s admission would rest with the schools, and no compulsion would take 
place.  If a school wishes to follow the NCAA’s example and admit a past violator or 
require a probationary period between time of violation and admittance, then the 
choice lies with that school’s admissions committee.  If an institution wishes to grant 
a past violator leniency, then this decision is theirs as well. 
In addition, students who take standardized tests under the legal influence189 of 
prescription stimulants should have their scores flagged.  The flag would indicate 
that the student was under something similar to a therapeutic use exemption for the 
drug. Prescription stimulants have been proven to enhance the academic performance 
                                                                
187See Interview with John Doe, supra note 1. John Doe indicated that he would not have 
taken Adderall before the LSAT had he known there was a possibility that he may have to 
submit to a drug test.  
188See Connolly, supra note 15, at 179. 
189Under the legal influence refers to students who have a valid medical prescription for 
the drugs. 
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of students legitimately diagnosed with ADHD.190  A student who takes the test 
under a therapeutic use exemption for prescription stimulants should have his scores 
flagged because it will be difficult or even impossible to tell whether the enhancing 
effect will compensate for the ADHD condition, or enhance his performance beyond 
a level of equality.  The institution should be notified that the prescription stimulants 
were legitimately taken and reported to the standardized test administrators.  In this 
way, the institutions themselves may decide how to treat these scores. 
It is hoped that implementation of this system, similar to that found in sports law, 
will deter students from illicitly taking prescription stimulants to enhance their 
performance on standardized tests.  Performance on these tests should be considered 
as just as important as performance in an athletic competition.  Accordingly, an 
effort to level the academic playing field, as occurs on the sports field, should be 
made. 
VII.  POSSIBLE CONCERNS 
A.  Is it an illegal Search? 
One possible criticism of conducting random drug tests for students taking 
standardized tests is that such tests might constitute an illegal search and seizure.191  
Random drug tests, even those whose results are ultimately submitted to state 
universities, do not violate the Fourth Amendment’s prohibition against 
unreasonable searches and seizures.192 
First, the Fourth Amendment protects against only state action.  In order for this 
type of drug testing to violate the Fourth Amendment, the organizations that 
administer standardized tests must be seen as state actors, or the process of state 
universities viewing the results of these tests must involve state action to the point of 
warranting Fourth Amendment protections.193  
The NCAA, a comparable institution in a comparable situation, has not been 
considered a state actor for purposes of determining whether constitutional 
limitations on its actions apply.194  In NCAA v. Jerry Tarkanian, 488 U.S. 179 
(1988), the Supreme Court addressed the issue of whether the NCAA’s action in 
sanctioning a college basketball coach for violating NCAA rules involved state 
action subject to Fourteenth Amendment protections.195  An NCAA committee 
investigation found that Tarkanian violated a number of NCAA rules.  The NCAA 
                                                                
190Conte, supra note 38. 
191 The Fourth Amendment reads as follows: The right of the people to be secure in their 
persons, houses, papers, and effects, against unreasonable searches and seizures, shall not be 
violated, and no Warrants shall issue, but upon probable cause, supported by Oath or 
affirmation, and particularly describing the place to be searched, and the persons or things to 
be seized. U.S. CONST. amend. IV. The Fourth Amendment prohibits federal officials from 
conducting illegal searches and seizures, while the Fourteenth Amendment, per Mapp v. Ohio, 
367 U.S. 643 (1961), also incorporated this restriction upon state actors. 
192See generally NCAA v. Tarkanian, 488 U.S. 179 (1988). 
193Id. 
194Id. 
195Id. at 191-92. 
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sanctioned Tarkanian’s employer, the University of Nevada – Las Vegas (UNLV), a 
state university.  Additional sanctions would have been imposed if the university had 
not removed Tarkanian during the probationary period imposed on the university. 
Tarkanian argued that since UNLV was a state entity, the NCAA’s compelling the 
university to suspend him constituted state action subject to Fourteenth Amendment 
due process limitations.196  
The Court recognized that no matter how arbitrary or unfair the conduct is, if it is 
of a private nature, constitutional restrictions do not apply.197  Conduct that is 
comprised of even partial state action may be subjected to Constitutional restrictions. 
To determine whether indirect state action warrants Fourteenth Amendment 
protection, the Court examined factors such as whether the “[s]tate creates the legal 
framework governing the conduct,” whether the state “delegates its authority to the 
private actor,” and whether the private organization “knowingly accepts the benefits 
derived from unconstitutional behavior.”198 Essentially, the question is “whether the 
State provided a mantle of authority that enhanced the power of the harm-causing 
individual actor.”199  In Tarkanian, the NCAA was the entity that created the legal 
framework for the action and compelled the state entity to act.  Accordingly, the 
Court held that the NCAA was not a state actor, and thus no constitutional 
restrictions on state action applied. 
Though Tarkanian involved the Due Process Clause – the issue presented with 
standardized tests is the same – are the standardized test administrators  acting under 
color of state law to a point that warrants constitutional protection to governmental 
abuse?  Under the Tarkanian analysis, it should be clear that testing of this type does 
not involve state action to a point that warrants constitutional protection.  The 
organizations administering standardized tests200 do not receive any kind of 
governmental funding or direction in implementation of the organization’s governing 
framework.  They do not operate under any government-delegated authority, and 
neither the state nor federal government derive any benefit from unconstitutional 
behavior in the administration of standardized tests. 
In the unlikely event that these random drug tests are found to be unreasonable, 
no constitutional protection preventing them applies.  The possibility of random drug 
testing would be a part of the contractual relationship between the student and the 
standardized test administrator.   
Though the direct drug testing itself may not involve state action, some may 
contend that state action is involved when scores are submitted to state universities 
for decision.  It is unlikely that such indirect state action will be sufficient to 
implicate constitutional restrictions.  Tarkanian disputed the fact that the NCAA was 
an organization founded in part by state entities (state universities).201  The NCAA 
                                                                
196See generally Tarkanian, 488 U.S. 179. 
197Id. 
198Id. at 192. 
199Id. 
200The organizations include LSDAS, the College Board, and ACT. 
201NCAA, History of the NCAA, http://www.ncaa.org/about/history.html (Last visited 
Feb. 5, 2007).  President Theodore Roosevelt, in 1905, mandated that the Presidents of 
Universities meet to discuss reforms to the violent nature of the game of football.  Id.  Thirteen 
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rules that were followed in this situation were partially a product of state input.202 
The University of Nevada-Las Vegas, a state entity, along with many other state 
institutions were responsible for promulgating these rules.203  Tarkanian argued that 
the NCAA was sufficiently involved with state entities to subject its regulations to 
Constitutional protections against state action.204 
The Tarkanian Court, however, found that only a small number of state entities 
contributed to these rules, especially in comparison to the number of private 
universities involved.205  Thus, the Court held that state involvement was not 
sufficient to consider the NCAA’s action a “state action.”206 In this way, the Court 
found that a state entity’s mere involvement in an action does not make that action a 
“state action.”207  Rather, there must be a sufficient amount of state involvement in 
order to subject that action to Fourteenth Amendment restrictions.208 
This situation is similar to state institutions receiving the drug test results of 
standardized test-takers.  A state entity is involved in this action – a state school is 
receiving the result of the drug test.  However, the entity actually conducting the 
drug test, the standardized test administrator, is a private institution.  Thus, it is likely 
that a reviewing court will hold that a review of drug test results by state universities 
is not sufficient to be considered a state action. 
The state entity’s involvement in receiving the drug test results, like that of the 
state entity involvement in the promulgation of NCAA rules, is minimal.  Tarkanian 
considered the relative weight of state involvement in an activity to determine 
whether it should be, considered a state action.  A court considering the situation 
presented in this note will likely apply the same standard as used in Tarkanian and 
reach the same result. Since it is likely that the review of drug test results by state 
universities will not be considered a state action, the fourth or fourteenth amendment 
protections will not apply.  
                                                           
universities met in December of 1905 to discuss these reforms and to establish a uniform set of 
rules. During the next meeting, on December 28, sixty-two institutions were represented, 
including many state universities. Id. These institutions formally established the Intercollegiate 
Athletic Association of the United States, which would later become known as the National 
Collegiate Athletic Association (NCAA) in 1910.  Id.  Representatives of institutions would 
meet at NCAA meetings to establish bylaws that govern the sports in which their institutions 
participate.  Id.  In this way, the NCAA is an entity partially founded and comprised by state 
actors. 
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204Tarkanian, 488 U.S. at 197. 
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207Id. at 193-94 
208Id.  
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B.  Reporting Therapeutic Use Exemptions – Does it Violate the ADA? 
Another major criticism of implementing random drug testing for standardized 
tests is that it might violate the ADA.209  Title III, Section 309 of the ADA, which 
applies to places of public accommodation, states “[a]ny person that offers 
examinations or courses related to applications, licensing, certification, or 
credentialing for secondary or post-secondary education, professional, or trade 
purposes shall offer such examinations or courses in a place and manner accessible 
to persons with disabilities or offer alternative accessible arrangements for such 
individuals.”210  
Under the proposed system outlined in this note, those students legitimately 
prescribed ADHD medications would generally qualify for a therapeutic use 
exemption, and the fact that they took these drugs before taking the standardized test 
would be reported along with their scores.  Students with therapeutic use exemptions 
for prescription stimulants would be accommodated, and thus the direct requirement 
of the ADA should be satisfied.211  A problem arises because flagging only occurs 
when disabled students are granted accommodations.  Thus, the flagging vicariously 
indicates that the student is disabled in some way, though the actual disability is 
concealed.212  Some may contend that this practice could implicate ADA restrictions.  
Currently, the Law School Admissions Council reports, along with the scores, 
whether the student took the test under accommodated conditions.213 The most 
common report is that a student is granted more time to complete each section of the 
examination.214  The LSAT and MCAT have been able to continue this practice, 
despite ADA concerns.215  Likewise, the proposed system described in this note 
should be able to report therapeutic use exemptions without violating the ADA. 
It has been proven that prescription stimulants enhance the academic 
performance of not only those students who illicitly take them, but also of those 
students diagnosed with ADHD.216  It is difficult, if not impossible to tell whether 
                                                                
209See Americans with Disabilities Act, 42 U.S.C.S. §§ 12101-12213 (LexisNexis 2007); 
see also Dep’t of Justice, ADA homepage, http://www.usdoj.gov/crt/ada/adahom1.htm (Last 
visited Feb. 5, 2007). The ADA is federal legislation enacted to prevent federal and state 
governments from discriminating in employment on the basis of a person’s disability.  Id. 
21042 U.S.C.S. § 12189 (LexisNexis 2005).  
211See id. (“Any person that offers examinations or courses related to applications, 
licensing, certification, or credentialing for secondary or post-secondary education, 
professional or trade purpose shall offer such examinations or courses in a place and manner 
accessible to persons with disabilities or offer alternative accessible arrangements for such 
individuals.”). 
212See LSAC, Accommodated Testing, http://www.lsac.org/LSAC.asp?url=lsac/ 
accommodated-testing.asp (Last visited Feb. 5, 2007). 
213 Id. 
214Id.  
215See Michael Slipsky, Recent Development: Flagging Accommodated Testing on the 
LSAT and MCAT: Necessary Protections of Academic Standards of the Legal and Medical 
Communities, 82 N.C.L. REV. 811, 813 (2004). 
216See James, supra note 46, at 1268.  
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this academic enhancing effect merely puts ADHD students on the performance level 
of other healthy students or whether it in fact gives them an unfair competitive 
edge.217  This difficulty is similar to the one occurring when students are given 
accommodated testing conditions, such as more time to complete a test.218 It is 
difficult to tell whether these conditions merely level the playing field by 
compensating for the students disability or whether these conditions in fact do more. 
Currently, the LSAT and MCAT are the only major standardized tests to report 
the fact that a test was taken under accommodated circumstances.219  The 
Educational Testing Service, which administers the Scholastic Aptitude Test 
(SAT)220 and the Graduate Admissions Test (GRE),221 agreed to stop indicating that 
tests were taken under accommodated circumstances (this practice is generally 
referred to as “flagging.”).222  The American College Testing Program (hereinafter 
“ACT”)223 also discontinued flagging scores.224  The LSAT and MCAT, on the other 
hand, continue to flag scores, allowing admissions committees to decide just how 
much they want to weigh accommodated testing versus the student’s disability.225 
This practice should be emulated for students with therapeutic use exemptions for 
prescription stimulants taken before standardized tests and should not be found to 
violate the ADA.  
A claim that seeks injunctive relief in a federal court to prevent flagging would 
have to show that the defendant’s conduct is likely to result in the plaintiff 
experiencing a future injury.226  In the case of John Doe v. National Board of 
Medical Examiners, 99 F.3d 146 (3rd Cir. 1999), the plaintiff was a doctor with 
multiple sclerosis who had taken his state licensing medical exam under 
accommodated conditions.227  The Board of Medical Examiners, which administers 
the test, reported to medical internship and residency programs that the test was 
taken under accommodated circumstances, along with the actual score.228 Doe 
                                                                
217 See supra Section II.B. 
218 See supra Section VIIB. 
219See Slipski, supra note 215, at 813. 
220The College Board, Meet the SAT, http://www.collegeboard.com/parents/tests/meet-
tests/21295.html (last visited Feb. 5, 2007).   
221GRE, Homepage, http://www.ets.org/portal/site/ets/menuitem.fab2360b1645a1de9b3a0 
779f1751509/?vgnextoid=b195e3b5f64f4010VgnVCM10000022f95190RCRD (last visited 
Feb. 5, 2007).  
222See Slipski, supra note 215, at 813. 
223ACT, What is the ACT, http://www.actstudent.org/faq/answers/what.html (last visited 
Feb. 5, 2007).  
224See Slipski, supra note 215, at 812-813. 
225 See Id. 
226See Roe v. Operation Rescue, 919 F.2d 857, 864 (3rd Cir. 1990). 
227John Doe v. Nat’l Bd. of Med. Exam’rs, 99 F.3d 146, 150 (3rd Cir. 1999).  The plaintiff 
was given extra time to complete the exam and a seat next to the bathroom. See Id. 
228 Id. 
2007-08] COMBATING THE UNFAIR COMPETITIVE EDGE 175 
claimed that this practice violated the ADA.229  The Third Circuit held that “Section 
309 [of the ADA] does not explicitly bar the practice of flagging the test scores of 
examinees who have received testing accommodations.”230  It next addressed the 
question of whether flagging was implicitly banned by any ADA section.231 
The court noted that the Department of Justice’s regulations interpreting section 
309 likewise did not specifically ban flagging.232 The Department’s interpretation of 
section 309 required that:  
The examination is selected and administered so as to best ensure that, 
when the examination is administered to an individual with a disability 
that impairs sensory, manual, or speaking skills, the examination 
results accurately reflect the individual’s aptitude or achievement level 
or whatever other factor the examination purports to measure, rather 
than reflecting the individual’s impaired sensory, manual, or speaking 
skills (except where those skills are the factors that the examination 
purports to measure.)233 
Nowhere does this text mention that accommodations must remain confidential. 
Rather, it requires only that they be made. 
Doe also argued that the indirect indication that he is a disabled person violated 
the ADA’s general prohibition on discrimination because it aided third parties234 in 
discriminating against him.235  Again, the court noted that no provision of Title III of 
the ADA236 specifically required that implicated institutions keep evidence of 
disability confidential.237  In addition, the possibility of facilitating discrimination is 
not sufficient to establish an ADA claim.238  Rather, Doe would have had to prove 
that the testing service itself discriminated, which did not happen in his case.239 
In the alternative, even if it could be proven that flagging scores produced by 
students under therapeutic use exemptions was in some way discriminatory, it is 
likely that ADHD does not qualify for ADA protection.240  In Knapp v. City of 
                                                                
229 Id. 
230Id. at 155. 
231 Id. 
232 Id. at 156. 
233Id.  (citing 28 C.F.R. § 36.309(b)(1)(i)). 
234In this case, the third parties were the medical residency and internship programs to 
whom Doe sent his test scores. 
235Nat’l Bd. of Med. Exam’rs, 199 F.3d at 158. 
236This is the title under which section 309 is located. It generally refers to places of public 
accommodation, as opposed to governmental entities, which are referred to in the first two 
titles. 
237Title I, on the other hand, does require this confidentiality. However, it is not implicated 
here – only title III is implicated in this situation.  
238 Id. 
239See Nat’l Bd. of Med. Exam’rs, 199 F.3d at 158. 
240See generally Knapp v. City of Columbus, 192 F. App’x. 323 (6th Cir. 2006). 
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Columbus, 92 F. App’x 323 (6th Cir 2006), the Sixth Circuit held that ADHD was 
not a disability protected by the ADA.241  The case involved three plaintiffs who 
alleged that their medically diagnosed condition of ADHD qualified them for ADA 
protection.242  The three plaintiffs, who were firemen, requested accommodations in 
taking the Columbus Civil Service Commission examination and the Fire Captain’s 
Promotion examination.243 In requesting accommodation, one plaintiff submitted 
doctor statements indicating that he had “significant ADHD symptoms” which had 
an “adverse impact upon day-to-day functioning.”244  The second plaintiff submitted 
a doctor’s letter into evidence that indicated that the plaintiff “experiences significant 
distractibility, restlessness, and impulsivity that result in impairments.”245  The third 
plaintiff admitted to only moderate ADHD.246 
The court noted that the ADA defined disability as “a physical or mental 
impairment that substantially limits one or more of the major life activities of such 
individual,” “a record of such impairment,” or “being regarded as having such an 
impairment.”247  In determining whether ADHD has limited an individual’s learning 
capacity to the point that it “substantially limits one or more of the major life 
activities”248 of the individual, the court asks “whether the claimant is unable to 
perform the variety of tasks central to most people’s daily lives, not whether the 
claimant is unable to perform the tasks associated with her specific job.”249  The 
court further noted that “[t]he requirements of the ADA are so demanding, that even 
if these critically important tasks are occasionally disrupted, a jury could still find the 
absence of a disability under the ADA.”250 
Though qualifying a condition as an ADA-protected disability is difficult, the 
court noted that this determination is conducted on an individual basis.251  In the 
specific cases presented to the Knapp court, it did not find that ADHD had affected 
the individuals’ lives to the point that it substantially limited one or more of the 
individuals’ life activities.252 
Thus, the court seemingly set a high bar for determining that ADHD qualifies as 
an ADA-protected disability requiring accommodation.  A student must show that 
his ADHD substantially impairs one of his life activities – a difficult assertion to 
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247Id. at 328 (citing 42 U.S.C.S. § 12102(2)).  
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make.  Likely, many students who have made it to the level of applying for 
undergraduate or graduate school will not be able to show that their condition has 
substantially impaired one of their life activities.  Although this analysis is conducted 
on a case-by-case basis, it seems likely that most claims that ADHD is protected by 
the ADA would fail. 
Similarly, a claim would likely fail if it asserted that flagging scores of students 
under a therapeutic use exemption for prescription stimulants violates the ADA. 
Even if in a particular situation the court decides to treat a student’s ADHD as an 
ADA-protected disability, Title III of the ADA requires only that the student be 
accommodated when taking a standardized test.253  It does not prohibit disclosure of 
accommodation, nor does it necessarily follow that disclosure leads to 
discrimination. Therefore, because it is unknown just how accommodations in the 
form of prescription stimulants exactly affect test scores of ADHD students, the best 
policy is to let the admissions committee decide how these scores should be treated. 
VIII.  CONCLUSION 
Standardized tests are becoming an increasingly important criterion in admissions 
decisions. Because of this trend, standardized tests have become more and more 
competitive. Students taking standardized tests often will do everything they can to 
achieve the best result possible, and some students will not stay within the legal 
bounds to achieve their goals.  
Prescription stimulants such as Adderall and Ritalin have a proven enhancing 
effect on the academic performance of not only those diagnosed with ADHD, but 
also on presumably healthy individuals. Because of the increased proliferation of 
these drugs and because of increased awareness that these drugs can enhance one’s 
academic performance, documented abuse has occurred. Students are using these 
drugs to enhance their academic performance on standardized tests, and this practice 
needs to be stopped. 
The solution to this increasing problem is found in random drug testing of these 
individuals, similar to what occurs in most sporting events. When athletes enter into 
a competition, they often sign contracts in which they agree not to use certain 
substances, although legal, that will unfairly enhance their performance.  Though 
therapeutic use exemptions do exist, they are difficult to acquire and always require 
reporting.  
Thus, individuals taking standardized tests should be subjected to drug testing 
similar to those undergone by many athletes.  Like the NCAA and USADA 
examples, students would be tested mostly at random, and certain safeguards 
ensuring accuracy of the test should be taken.  If a student tests positive for a 
prescription stimulant and did not apply for the requisite therapeutic use exemption, 
then his score should be flagged as having been procured while under the influence 
of illicitly taken prescription stimulants.  Schools should then be free to decide how 
they want to treat the scores in their admissions decisions. 
Similar to the LSAT and MCAT’s treatment of scores taken under 
accommodated conditions, scores procured by students legitimately taking 
prescription stimulants should be flagged. Because these drugs have a proven 
academic enhancing effect on students’ performance, and because it is difficult if not 
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impossible to tell whether this enhancing effect merely evens the abilities of an 
ADHD student with a healthy student or further enhances them, scores procured by 
students with therapeutic use exemptions for prescription stimulants should be 
flagged when submitted to schools.  Some may contend that flagging violates the 
American with Disabilities Act, but the ADA only requires that qualified individuals 
be accommodated and does not prohibit disclosure of accommodation, and therefore 
no ADA violation would likely occur. 
Some may also contend that random drug testing may constitute an unreasonable 
search and seizure and violate either the Fourth and/or Fourteenth Amendments. 
Because state action to the point triggering Fourth or Fourteenth Amendment 
involvement does not occur when the tests are conducted, a determination of whether 
the tests constitute a search or seizure, or whether they are unreasonable, is not 
necessary. 
Drug tests ensuring that the playing field in standardized tests remains level are 
needed.  Proper steps should be taken to implement this protection so that students 
willing to break the rules are not rewarded with higher standardized test scores and 
consequently better chances at admission.  
